Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs Valley National Bancorp Common Stock (VLY) Price & Performance

Dr. Reddy's Laboratories Ltd Common StockTrade
Valley National Bancorp Common StockTrade

Price performance (Past 24H)

Key statistics

Dr. Reddy's Laboratories Ltd Common Stock vs Valley National Bancorp Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while Valley National Bancorp Common Stock trades at $12.39 (market cap $6.92B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is the larger of the two by market cap, and Valley National Bancorp Common Stock pays the higher dividend (3.51%). Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Valley National Bancorp Common Stock for 6 Days on average.

RDYVLY
Market Cap
$10.78B$6.92B
Volume
2,724,3436,202,090
Sector
HealthFinancials
52-Week High
$15.38$15.19
52-Week Low
$11.38$9.72
Typical Hold Time
0 Days6 Days
Enterprise Value
$10.68B$9.43B
Dividend Yield
0.65%3.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Valley National Bancorp Common Stock

Valley National Bancorp (VLY) trades at $12.53, down 0.87% with a bearish technical outlook. The stock shows strong fundamentals with a P/E of 10.61 and P/B of 0.91, indicating potential undervaluation. Recent earnings show mixed results with Q2 2026 missing estimates, but revenue growth remains solid at $2.2B for 2026. The company is actively expanding through acquisitions including Bluevine and Providence Financial to strengthen its deposit base and Chicago market presence.

Analyst consensus remains bullish with 62% buy ratings and a $16.50 price target, suggesting 32% upside potential. Key risks include integration challenges from recent acquisitions and higher operating expenses impacting margins. The upcoming Q3 2026 earnings report on October 22 will be crucial for validating growth trajectory amid current bearish technical signals.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDY
100% Buy0% Sell
Avg holding period · 0 Days
VLY

No sentiment data available yet.

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →

About Valley National Bancorp Common Stock

Valley National Bancorp is a financial holding company whose main subsidiary is Valley National Bank. It provides commercial, retail, trust, and investment services across several U.S. states.

Read more on VLY →